CD81-guided heterologous EVs present heterogeneous interactions with breast cancer cells
Authors:
Preprint
Abstract
Extracellular vesicles (EVs) are cell-secreted particles conceived as natural vehicles for intercellular communication. The intrinsic biocompatibility, stability in biofluids, and heterogeneous molecular cargo of EVs promise advancements in targeted therapy applications. However, predicting cell-targeting spectrum and cargo delivery are fundamental challenges for exploiting EVs or hybrid formulations. In this work, we combined cell-based and biochemical approaches to understand if secreted EVs show predictable EV-cell interactions and consequent cargo delivery. We exploited the tetraspanin CD81 to encode full-length recombinant proteins with a C-terminal GFP reporter encompassing or not Trastuzumab light chains targeting the HER2 receptor. These fusion proteins participated in vesicular trafficking dynamics and accumulated on secreted EVs when transiently over-expressed in HEK293T cells. Despite the presence of GFP, secreted EV populations retained a HER2 receptor-binding capacity and were used in EV-cell interaction assays. In time-frames where the global GFP spot distribution did not change between HER2-positive (SK-BR-3) or –negative (MDA-MB-231) breast cancer cell lines, the HER2 manipulation in isogenic cells remarkably affected the tropism of heterologous EVs. In this line, secreted doxorubicin-EVs, which showed improved efficacy compared to the free drug, had a reduced cell-killing activity on SK-BR-3 with a knocked-out HER2 receptor. Interestingly, the fusion protein-corresponding transcripts also present as full-length mRNAs in recombinant EVs could reach orthotopic breast tumors in JIMT-1-xenografted mice, as detected by ddPCR in tissue biopsies, improving our sensitivity in detecting bioavailable cargoes. These data show multiple mechanisms underlying EV-cell interactions and prioritize the profiling of surfaceomes for better comprehension of cell engagement and design new generations of EV-based nanovehicles.Keywords
All Related Versions
- Published version: Journal of Biomedical Science, 31 (1), 1.
This publication has 46 references indexed in Scilit:
- Detailed Analysis of Protein Topology of Extracellular Vesicles–Evidence of Unconventional Membrane Protein OrientationScientific Reports, 2016
- Generation of a novel transgenic rat model for tracing extracellular vesicles in body fluidsScientific Reports, 2016
- Development of exosome surface display technology in living human cellsBiochemical and Biophysical Research Communications, 2016
- Sequential fractionation and isolation of subcellular proteins from tissue or cultured cellsMethodsX, 2015
- Activation of nucleation promoting factors for directional actin filament elongation: Allosteric regulation and multimerization on the membraneSeminars in Cell & Developmental Biology, 2013
- Syndecan–syntenin–ALIX regulates the biogenesis of exosomesNature Cell Biology, 2012
- TrastuzumabThe Oncologist, 2011
- Hsp90 inhibitor 17-AAG reduces ErbB2 levels and inhibits proliferation of the trastuzumab resistant breast tumor cell line JIMT-1Immunology Letters, 2006
- Structure of the Tetraspanin Main Extracellular DomainJournal of Biological Chemistry, 2001
- CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifsThe EMBO Journal, 2001